Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: J Bone Miner Res. 2023 Nov 16;38(12):1877–1884. doi: 10.1002/jbmr.4931

Table 2C:

Spine BMAT composition biomarkers with adjustment for age, HDL, LDL, and statin use. Data shown as adjusted mean ± standard error

BMAT markers Male Female
Control (n=16)  T2D (n=18) P-value β coeff. 95% C.I. of difference Control (n=21) T2D (n=21) P-value β coeff. 95% C.I. of difference
TFC (%) 81.4±1.6 76.9±1.1 0.04 −4.49 (−8.70, −0.27) 82.3±2.0 80.0±2.1 0.48 −2.33 (−8.84, 4.18)
UFC (%) 3.1±0.1 2.8±0.2 0.21 −0.31 (−0.80, 0.17) 2.9±0.2 3.2±0.3 0.41 0.27 (−0.37, 0.90)
SFC (%) 42.5±1.2 38.8±1.0 0.03 −3.70 (−7.02, −0.39) 41.6±1.6 41.7±1.7 0.98 0.08 (−5.22, 5.38)